1.59
Skye Bioscience Inc (SKYE) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
12.73%
11.06
|
12.67 | 14.90 | 13.26 | 18.24 |
| Operating Income/Loss |
12.73%
-11.06
|
-12.67 | -14.90 | -13.26 | -18.24 |
| Nonoperating Income/Loss |
68.55%
0.2781
|
0.165 | 0.4536 | 0.5099 | 0.6225 |
| Income/Loss From Continuing Operations Before Tax |
13.80%
-10.78
|
-12.51 | -14.44 | -12.75 | -17.62 |
| Income Tax Expense/Benefit |
0.0034
|
- | - | - | 0.0034 |
|
|
13.77%
-10.79
|
-12.51 | -14.44 | -12.75 | -17.62 |
| Basic Average Shares |
0.03%
39.69
|
39.68 | 0.00815 | 39.67 | 39.66 |
| Diluted Average Shares |
0.03%
39.69
|
39.68 | 0.00815 | 39.67 | 39.66 |
| Basic Earnings Per Share |
15.62%
-0.27
|
-0.32 | -0.36 | -0.32 | -0.44 |
| Diluted Earnings Per Share |
15.62%
-0.27
|
-0.32 | -0.36 | -0.32 | -0.44 |
자본화:
|
볼륨(24시간):